Filanesib (ARRY-520) is a potent and selective kinesin spindle protein (KSP/Eg5) inhibitor with an IC50 of 6 nM, demonstrating anti-proliferative activity. It is widely used in cancer research, particularly in studying mitosis, and has shown efficacy in both in vitro cellular assays and in vivo xenograft models of various malignancies.